You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemo-resistance

Showing 1 - 25 of 8,950
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Pembrolizumab, Paclitaxel, Cisplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Cancer Center
Mar 6, 2022

Plasmodium Falciparum Malaria Trial in Worldwide (malaria elimination using DP and low-dose primaquine)

Completed
  • Plasmodium Falciparum Malaria
  • malaria elimination using DP and low-dose primaquine
  • Pailin, Cambodia
  • +4 more
Aug 26, 2020

EGFR Activating Mutation, Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Winston-Salem (drug, biological,

Terminated
  • EGFR Activating Mutation
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jan 28, 2021

Head Cancer, Neck Cancer Trial in Grenoble, Lyon, Pierre-Bénite (CHEMRAD assay)

Completed
  • Head Cancer
  • Neck Cancer
  • CHEMRAD assay
  • Grenoble, France
  • +3 more
Dec 23, 2021

Dental Caries Trial in Alexandria (BRIX3000, papacarie, hand excavation)

Recruiting
  • Dental Caries
  • BRIX3000
  • +2 more
  • Alexandria, Egypt
    Faculty of Dentistry
Aug 7, 2023

Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

Not yet recruiting
  • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 16, 2023

Metastatic Lung Cancer Trial in Beer sheva, Petah Tikva (Antibiotics, FMT (Fecal Microbiota Transplantation), Placebo

Not yet recruiting
  • Metastatic Lung Cancer
  • Beer sheva, Israel
  • +1 more
Aug 14, 2022

Acute Myeloid Leukemia Trial in Italy (Venetoclax and Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax and Decitabine
  • San Giovanni Rotondo, Foggia, Italy
  • +24 more
Aug 8, 2022

H19 in Acute Lymphoblastic Leukemia.

Not yet recruiting
  • Acute Lymphoid Leukemia
    • (no location specified)
    Jul 11, 2023

    Hypopharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Larynx Cancer Trial in United Kingdom (AZD1775,

    Completed
    • Hypopharynx Squamous Cell Carcinoma
    • +2 more
    • Birmingham, West Midlands, United Kingdom
    • +5 more
    Nov 9, 2022

    Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer Trial in New Haven (Dapagliflozin 10mg)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Dapagliflozin 10mg
    • New Haven, Connecticut
      Yale Cancer Center Smilow Cancer Hospital
    Aug 3, 2023

    Gestational Trophoblastic Neoplasias (GTN) Trial in France (Avelumab administration at 10mg/kg)

    Completed
    • Gestational Trophoblastic Neoplasias (GTN)
    • Avelumab administration at 10mg/kg
    • Bordeaux, France
    • +5 more
    Sep 1, 2021

    CLL/SLL Trial in France (First line therapy)

    Not yet recruiting
    • CLL/SLL
    • First line therapy
    • Amiens, France
    • +57 more
    Oct 21, 2022

    NSCLC Metastatic Trial in Salt Lake City (Durvalumab, Pemetrexed, Carboplatin)

    Recruiting
    • Non-Small Cell Lung Cancer Metastatic
    • Salt Lake City, Utah
      Huntsman Cancer Institute at University of Utah
    Mar 1, 2022

    Colorectal Cancer Trial in Bellinzona (Metronidazole Oral)

    Not yet recruiting
    • Colorectal Cancer
    • Metronidazole Oral
    • Bellinzona, Ticino, Switzerland
      Oncology Institute of Southern Switzerland
    Feb 17, 2023

    Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Aurora (Inspiratory muscle strength training, Sham Inspiratory muscle strength

    Not yet recruiting
    • Hodgkin Lymphoma
    • Non Hodgkin Lymphoma
    • Inspiratory muscle strength training
    • Sham Inspiratory muscle strength training
    • Aurora, Colorado
    • +1 more
    Jun 30, 2023

    Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement

    Recruiting
    • Lymphoma
    • +4 more
    • Vysis LSI MYC Break Apart Rearrangement Probe Kit
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Aurora (sEphB4-HSA with chemo, Cetuximab, Radiation Therapy)

    Completed
    • Squamous Cell Carcinoma of Head and Neck
    • sEphB4-HSA with chemotherapy
    • +2 more
    • Aurora, Colorado
      University of Colorado Hospital
    Dec 9, 2022

    Micro and Macroscopic Level of Primary Central Nervous System

    Active, not recruiting
    • Primary Central Nervous System Lymphoma (PCNSL)
    • Tumor samples and MRI
    • Paris, France
      Groupe Hospitalier La Pitié Salpêtrière
    Feb 17, 2022

    Small Cell Lung Cancer, Lung Cancer Trial in Switzerland (Durvalumab, carboplatin, etoposide)

    Recruiting
    • Small Cell Lung Cancer
    • Lung Cancer
    • Aarau, Switzerland
    • +13 more
    Aug 12, 2022

    Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Newport Beach, Orlando (GL-ONC1 alone, or in

    Completed
    • Ovarian Cancer
    • +2 more
    • GL-ONC1 alone, or in combination with chemotherapy with or without bevacizumab
    • Newport Beach, California
    • +1 more
    Jan 3, 2023

    Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Prostate Cancer Trial in San Antonio (High Intensity

    Recruiting
    • Prostate Cancer Metastatic
    • +3 more
    • High Intensity Interval Training
    • San Antonio, Texas
      UT Health San Antonio
    Feb 17, 2022

    Study of Predictive Factors of Chemoresistance in Ovarian Cancer

    Completed
    • Ovarian Cancer
    • Cancer treatment
    • Rennes, France
      LAVOUE
    Aug 16, 2021

    Triple Negative Breast Cancer Trial in Ile-Ife, Ibadan, Lagos (Epirubicin, Cyclophosphamide, Paclitaxel)

    Recruiting
    • Triple Negative Breast Cancer
    • Ile-Ife, Oshun, Nigeria
    • +3 more
    Feb 16, 2022

    DLBCL, High Grade B-Cell Lymphoma Trial in United States (Venetoclax, Rituximab, Etoposide)

    Completed
    • Diffuse Large B-Cell Lymphoma
    • High Grade B-Cell Lymphoma
    • Boston, Massachusetts
    • +5 more
    Aug 23, 2022